NCT05047770 - A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine | Biotech Hunter

Enrollment

2,013

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

August 29, 2022

Study Completion Date

August 31, 2022

Conditions

Herpes Zoster

Interventions

BIOLOGICAL

HZ/su

2 doses of HZ/su vaccine administered intramuscularly, either sequentially (HZ/suSeq Group) or simultaneously (HZ/suCoAd Group) with the mRNA-1273 booster dose. The second dose of HZ/su was administered 8 weeks after the first dose of HZ/su vaccine.

COMBINATION_PRODUCT

Flu D-QIV

1 dose of Flu D-QIV vaccine administered intramuscularly, either sequentially (FluD-QIVSeq Group) or simultaneously (FluD-QIVCoAd Group) with the mRNA-1273 booster dose.

BIOLOGICAL

mRNA-1273

1 booster dose of mRNA-1273 vaccine administered intramuscularly at Day 1 (all groups).

Trial Locations (46)

23502

GSK Investigational Site, Norfolk

29204

GSK Investigational Site, Columbia

29615

GSK Investigational Site, Greenville

29621

GSK Investigational Site, Anderson

30308

GSK Investigational Site, Atlanta

31904

GSK Investigational Site, Columbus

32256

GSK Investigational Site, Jacksonville

32801

GSK Investigational Site, Orlando

33135

GSK Investigational Site, Miami

33143

GSK Investigational Site, Miami

33173

GSK Investigational Site, Miami

33461

GSK Investigational Site, Lake Worth

33462

GSK Investigational Site, Atlantis

33912

GSK Investigational Site, Fort Myers

34471

GSK Investigational Site, Ocala

38119

GSK Investigational Site, Memphis

39531

GSK Investigational Site, Biloxi

40509

GSK Investigational Site, Lexington

43213

GSK Investigational Site, Columbus

66606

GSK Investigational Site, Topeka

67042

GSK Investigational Site, El Dorado

67114

GSK Investigational Site, Newton

67207

GSK Investigational Site, Wichita

68114

GSK Investigational Site, Omaha

73072

GSK Investigational Site, Norman

73099

GSK Investigational Site, Yukon

73112

GSK Investigational Site, Oklahoma City

77090

GSK Investigational Site, Houston

77375

GSK Investigational Site, Tomball

77706

GSK Investigational Site, Beaumont

78229

GSK Investigational Site, San Antonio

78613

GSK Investigational Site, Cedar Park

83642

GSK Investigational Site, Meridian

84088

GSK Investigational Site, West Jordan

84107

GSK Investigational Site, Salt Lake City

85283

GSK Investigational Site, Tempe

87102

GSK Investigational Site, Albuquerque

92103

GSK Investigational Site, San Diego

97527

GSK Investigational Site, Grants Pass

98405

GSK Investigational Site, Tacoma

99204

GSK Investigational Site, Cheney

93030-5841

GSK Investigational Site, Oxnard

92103-6204

GSK Investigational Site, San Diego

34243-2878

GSK Investigational Site, Sarasota

68025-2592

GSK Investigational Site, Fremont

08009

GSK Investigational Site, Berlin